ProQR Therapeutics (PRQR) Asset Utilization Ratio (2014 - 2026)
ProQR Therapeutics (PRQR) posted Asset Utilization Ratio of 0.13 for Q1 2026, down 2.93% sequentially from 0.13 in Q4 2025, and up 4.57% YoY from 0.12 in Q1 2025.
ProQR Therapeutics (PRQR) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
ProQR Therapeutics has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.13 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 4.57% year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.13 (up 4.57% YoY) and the FY2025 annual result came in at 0.12, down 3.3% from the prior year.
- Asset Utilization Ratio eased to 0.13 in Q1 2026 per PRQR's latest filing, from 0.13 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.16 in Q3 2024 and troughed at 0.01 in Q1 2022.
- A 5-year average of 0.08 and a median of 0.08 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 2249.33% in 2022, down 84.74% in 2022.
- Over 5 years, Asset Utilization Ratio stood at 0.03 in 2022, then surged by 81.18% to 0.05 in 2023, then surged by 196.46% to 0.14 in 2024, then fell by 6.06% to 0.13 in 2025, then fell by 2.93% to 0.13 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.13, 0.13, and 0.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.16 |
| Jun 30, 2024 | 0.13 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.00 |